On Being Bipolar in Business

choi

WSJ Staff, On Being Bipolar in Business. Wall Street Journal, May 24, 2022, at page A12
https://www.wsj.com/articles/a-f ... isorder-11653167052
https://bingxo.com/a-former-ceo- ... s-bipolar-disorder/

Excerpt in the window of print: Bonobos co-founder shares his odyssey in a new book, 'Burn Rate.'

Note:
(a)
(i) In prin, the report ends with "move forward."
(ii) The company is named after s species of great ape in Africa -- looking similar to but smaller in size than chimpanzee.
(iii) The print article has a photo (same in that online) with caption: "Andy Dunn at the WSJ's Future of Everything Festival in New York, on May 17.
(iv) the book: Andy Dunn, Burn Rate; Launching a startup and losing my mind. Currency (an imprint of Penguin Random House), May 10, 2022.

(b) Dunn: "For Bonobos, we raised over $100 million of capital: Would we have been able to raise that money if I'd been on the record as having Bipolar 1?"

Ankit Jain and Paroma Mitram Bipolar Affective Disorder. StatPearls, May 1, 2022
https://www.ncbi.nlm.nih.gov/books/NBK558998/
("Manic-depressive disorder--more contemporarily identified as bipolar disorder (BD) * * * BD can be further subdivided into bipolar disorder I (BD I) and bipolar disorder II (BD II). The quintessential feature of BD I is the manifestation of at least one manic episode--although depressive episodes are common, only one manic episode in a lifetime is enough to label one with BD I. To be diagnosed with BD II, one must experience at least one hypomanic episode, without any history of any manic episodes. Both of these aforementioned manifestations must precipitate in the absence of any substance, iatrogenic agent, or organicity as such extant associations would be indicative of the diagnoses of 'substance/medication-induced bipolar and related disorder' and 'bipolar and related disorder due to another medical condition', respectively")